ArticleJMIR research protocols2026
A Culturally Tailored Mobile Health Intervention to Improve Quality of Life in Black Survivors With Prostate Cancer: Protocol for a Stratified Randomized Controlled Trial.
Article in JMIR research protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06651359 (Development and Preliminary Evaluation of a Tailored mHealth App Designed to Improve Quality-of-Life Outcomes in Ethnically-Diverse Black Prostate Cancer Survivors), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Development and Preliminary Evaluation of a Tailored mHealth App Designed to Improve Quality-of-Life Outcomes in Ethnically-Diverse Black Prostate Cancer Survivors (SAFE-CaPs)
Who cites it
1 citing paper in PubMed.
- From Availability to Access: A Mixed-Methods Study of Digital Prostate Cancer Survivorship Support for Black Men.Current oncology (Toronto, Ont.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
Abstract
backgroundProstate cancer (CaP) disproportionately affects Black men in the United States, leading to significant disparities in incidence, survival, and quality of life (QoL). Treatment-related side effects, including urinary dysfunction, pain, fatigue, and psychological distress, contribute to poor long-term outcomes. There is an urgent need for culturally-tailored, technology-based interventions to support symptom self-management and survivorship care.
objectiveThis study aims to develop, refine, and evaluate the Survivorship App for Ethnically Diverse Black Prostate Cancer Survivors (SAFE-CaPS), a tailored mobile health intervention designed to enhance QoL, improve symptom self-management, and provide psychosocial support.
methodsThis 12-month stratified randomized clinical trial will enroll 248 Black survivors with CaP (including native born, African-born, and Caribbean-born men) into the SAFE-CaPS intervention arm and standard care (SC) control group (1:1 allocation). Eligible participants are self-identified Black men (including native born, African-born, and Caribbean-born) aged 40 to 80 years with a confirmed CaP diagnosis within the past 5 years who own or are willing to use a smartphone. SC will consist solely of routine oncology or primary care follow-up, including clinic visits, referrals, and supportive services as needed, with no digital components. The SAFE-CaPS intervention, developed using the Insight platform, includes daily and weekly ecological momentary assessments of pain, urinary and bowel symptoms, sleep, fatigue, sexual function, mood, physical activity, and diet; adaptive educational modules addressing treatment-related side effects and culturally grounded survivorship concerns; automated symptom alerts prompting nurse follow-up and provider notification; and engagement features such as reminders, goal-setting, and literacy-appropriate content. Intervention content incorporates culturally tailored messaging, patient narratives, and feedback from prior qualitative work with ethnically diverse Black CaP. Stratified randomization will ensure balanced representation of ethnic subgroups. Primary outcomes include overall QoL. Secondary outcomes include specific symptom domains, mental health (depression and anxiety), health care engagement, and app acceptability. Assessments will occur at baseline, 3, 6, 9, and 12 months, and linear mixed models with intent-to-treat principles will evaluate intervention effects over time.
resultsThe study was funded in 2024, institutional review board approval was received in mid-2024, and the study began recruitment on August 24, 2025. Overall, 6 participants have been enrolled, with 2 in the SAFE-CaPS intervention and 4 in SC. Recruitment is expected to conclude in July 2027. Data analysis will occur in late 2027, with article preparation and publication planned for mid-2028 and early 2029. We hypothesize that SAFE CaPS participants will experience greater improvements in QoL, reduced symptom burden, and higher engagement in care compared to SC.
conclusionsThis study will provide critical evidence on the feasibility, acceptability, and preliminary effectiveness of a culturally tailored mobile health intervention designed to enhance survivorship outcomes among Black survivors with CaP, informing future large-scale trials and real-world implementation.
trial registrationClinicalTrials.gov NCT06651359; https://clinicaltrials.gov/study/NCT06651359. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/81503.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.